Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Carboplatin and Paclitaxel in Elderly Ovarian Cancer
NCT00401674Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2003
- Primary completion
- Jun 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in ovarian cancer, sponsored by National Cancer Institute. Started Jun 2003; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00401674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401674.